Sarcomere gene variants did not improve cardiac function in pediatric patients with dilated cardiomyopathy from Japanese cohorts
Preprint
Abstract
Background: Dilated cardiomyopathy (DCM) is a progressive myocardial disorder characterized by impaired cardiac contraction and ventricular dilation. Some patients with DCM could manifest improvement in these abnormalities called left ventricular reverse remodeling (LVRR). However, the detailed association between genotypes and clinical outcomes, including LVRR, particularly among pediatric patients, remains uncertain. Methods: We prospectively enrolled pediatric patients with DCM from Japanese multi-institutional centers between 2014 and 2023. We identified DCM-related genes and explored the association between gene variants and clinical outcomes, including LVRR, which was defined as any increase in left ventricular ejection fraction during the observation period. Results: A total of 123 pediatric patients (62 males; mean age of 8 months [range, 1–51 months]) were retrospectively enrolled. There were 50 pathogenic variants in 45 patients (35.0%). The most identified gene was MYH7 (14.0%), followed by RYR2 (12.0%), and TPM1 (8.0%). A novel variant in the CASZ1 gene (NM_001079843.2 c.3356G>A, p. Trp1119Ter) was identified. LVRR was achieved in 47.5% of patients. In patients with sarcomere gene variants, the left ventricular ejection fraction remained unchanged (31.4% to 39.8%, P = 0.1913), whereas it significantly increased in patients with non-sarcomere gene variants (33.4% to 47.8%, P = 0.0466) and in patients without gene variants (33.6% to 54.1%, P = 0.003). Conclusions: Pediatric patients with DCM exhibited a marked genetic heterogeneity with a different landscape from adults with DCM. LVRR was not uniform across functional gene groups, opening the door to tailor-made gene-guided prediction in pediatric patients with DCM. Clinical perspective: What is new?: Younger patients had predominance for DCM and risk factors for survival. LVRR occurrence was lower in the sarcomere gene group, and cardiac function failed to improve. What are the clinical implications?: LVRR was not uniform across functional gene groups, which opens the door to the adoption of an individualized prediction approach in DCM according to the genetic features.Keywords
This publication has 50 references indexed in Scilit:
- Predicting Outcome in Children with Dilated Cardiomyopathy: The Use of Repeated Measurements of Risk Factors for OutcomeESC Heart Failure, 2021
- A significance of school screening electrocardiogram in the patients with ventricular noncompactionHeart and Vessels, 2020
- A novel de novo CASZ1 heterozygous frameshift variant causes dilated cardiomyopathy and left ventricular noncompaction cardiomyopathyMolecular Genetics & Genomic Medicine, 2019
- Genetic Testing in Pediatric CardiomyopathyPediatric Cardiology, 2017
- CASZ1 loss-of-function mutation associated with congenital heart diseaseGene, 2016
- Genotype-phenotype associations in dilated cardiomyopathy: meta-analysis on more than 8000 individualsClinical Research in Cardiology, 2016
- Effect of Left Ventricular Reverse Remodeling on Long-Term Prognosis After Therapy With Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers and β Blockers in Patients With Idiopathic Dilated CardiomyopathyThe American Journal of Cardiology, 2011
- Vertebrate CASTOR Is Required for Differentiation of Cardiac Precursor Cells at the Ventral MidlineDevelopmental Cell, 2008
- Carvedilol for Children and Adolescents With Heart FailureJAMA, 2007
- Incidence, Causes, and Outcomes of Dilated Cardiomyopathy in ChildrenJAMA, 2006